Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
101 studies found for:    pelvic inflammatory disease AND (woman OR women OR female)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
Conditions: Pelvic Inflammatory Disease;   Chlamydia Infections
Intervention: Procedure: Screening for chlamydia using self-taken vaginal swabs
2 Completed The Role of Novel Organisms in Acute Endometritis
Condition: Pelvic Inflammatory Disease
Intervention: Other: no intervention
3 Completed To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
Conditions: Induced Abortion;   Postaboral Pelvic Inflammatory Disease;   Sexually Transmitted Infections
Interventions: Drug: Universal antibiotic prophylaxis;   Other: Screen-and-treat
4 Completed The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
Condition: Pelvic Inflammatory Disease
Interventions: Drug: ceftriaxone, doxycycline, placebo;   Drug: ceftriaxone, doxycycline, metronidazole
5 Completed Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
Condition: Pelvic Inflammatory Disease
Intervention:
6 Completed Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.
Condition: Pelvic Inflammatory Disease
Interventions: Drug: Ofloxacin;   Drug: Avelox (Moxifloxacin, BAY12-8039)
7 Recruiting Technology Enhanced Community Health Nursing (TECH-N) Study
Condition: Pelvic Inflammatory Disease (PID)
Intervention: Behavioral: Technology Enhanced Community Health Nursing
8 Completed Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
Condition: Pelvic Inflammatory Disease
Interventions: Drug: Moxifloxacin;   Drug: Ofloxacin;   Drug: Metronidazole
9 Completed Home Sampling Versus Conventional Sampling for Screening of Urogenital Chlamydia Trachomatis in Young Men and Women.
Conditions: Chlamydia Trachomatis;   Mass Screening
Intervention: Procedure: Home sampling (urine test) for uro-genital C.trachomatis.
10 Not yet recruiting Prevention of Diseases Induced by Chlamydia Trachomatis
Condition: Genital Chlamydia Trachomatis Infection
Interventions: Other: Testing for Ct infection immediately;   Other: Testing for Ct infection at the end of the study
11 Completed Mirena Post-marketing Surveillance in Japan
Condition: Contraception
Intervention: Drug: Levonorgestrel IUS (Mirena, BAY86-5028)
12 Completed A Comparison of Narrow Band Imaging (NBI) and Standard White Light Laporoscopy to Detect Endometriosis
Condition: Endometriosis
Interventions: Other: NBI;   Other: White light
13 Completed
Has Results
A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease
Condition: Pelvic Inflammatory Disease
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039);   Drug: Levofloxacin & Metronidazole
14 Terminated Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection
Condition: Infertility
Intervention: Procedure: Hydrosalpinx needle aspiration to arm 1
15 Completed An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)
Conditions: Infections;   Pelvic Infections
Interventions: Drug: MK0826, ertapenem sodium;   Drug: Comparator: Ticarcillin/Clavulanate
16 Completed Doxycycline Prophylaxis at Vacuum Aspiration Trial
Condition: Endometritis
Interventions: Drug: Doxycycline pre-operatively;   Drug: Doxycycline post-operatively
17 Completed Immunopathogenesis of Chlamydia
Condition: CHLAMYDIA INFECTIONS
Intervention: Other: No intervention, only observational
18 Not yet recruiting Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae
Condition: Pelvic Inflammatory Disease
Interventions: Drug: Comprehensive treatment of TCM;   Other: Expectant treatment
19 Completed
Has Results
Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan
Condition: Pelvic Inflammatory Disease
Intervention: Drug: Azithromycin
20 Recruiting Database of Pelvic Inflammatory Disease
Condition: Inflammatory Pelvic Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.